IRIS
GENTILE, Vittorio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.549
NA - Nord America 3.032
AS - Asia 2.013
SA - Sud America 313
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 1
Totale 11.932
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 3.368
US - Stati Uniti d'America 2.995
FI - Finlandia 790
SG - Singapore 753
IT - Italia 664
IE - Irlanda 662
CN - Cina 370
UA - Ucraina 361
HK - Hong Kong 315
GB - Regno Unito 273
BR - Brasile 271
VN - Vietnam 215
DE - Germania 172
KR - Corea 142
SE - Svezia 79
TR - Turchia 62
IN - India 61
GR - Grecia 55
FR - Francia 50
JP - Giappone 24
BD - Bangladesh 20
AR - Argentina 16
BE - Belgio 14
CA - Canada 13
MX - Messico 13
NL - Olanda 13
AT - Austria 11
ID - Indonesia 9
PK - Pakistan 9
ES - Italia 7
CH - Svizzera 6
EU - Europa 6
HU - Ungheria 6
PE - Perù 6
CZ - Repubblica Ceca 5
IQ - Iraq 5
UZ - Uzbekistan 5
ZA - Sudafrica 5
CO - Colombia 4
DO - Repubblica Dominicana 4
EC - Ecuador 4
IR - Iran 4
KE - Kenya 4
MA - Marocco 4
PY - Paraguay 4
RS - Serbia 4
CL - Cile 3
HN - Honduras 3
PL - Polonia 3
VE - Venezuela 3
AL - Albania 2
AZ - Azerbaigian 2
JO - Giordania 2
LT - Lituania 2
NP - Nepal 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
CR - Costa Rica 1
EG - Egitto 1
GA - Gabon 1
GE - Georgia 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
RO - Romania 1
SA - Arabia Saudita 1
SN - Senegal 1
SV - El Salvador 1
TW - Taiwan 1
Totale 11.932
Salva come PNG Salva come JPEG
Città #
Moscow 1.183
Helsinki 697
Dublin 661
Jacksonville 542
Santa Clara 383
Chandler 325
Hong Kong 315
Singapore 295
Caserta 201
San Jose 196
Ashburn 149
Seoul 136
Naples 109
Princeton 96
Medford 82
Ann Arbor 77
Ho Chi Minh City 69
Beijing 68
Boardman 68
Hanoi 58
Dallas 56
Memphis 50
San Mateo 49
Roxbury 41
Wilmington 39
Woodbridge 38
Hefei 37
Bengaluru 35
New York 31
Cambridge 30
Los Angeles 27
Aversa 26
Milan 25
Napoli 25
São Paulo 24
The Dalles 24
Des Moines 21
Dong Ket 18
Munich 15
Orem 15
Atlanta 13
Brussels 13
Rio de Janeiro 13
Rome 12
Bremen 10
Chicago 10
Belo Horizonte 9
Da Nang 9
Haiphong 9
Mountain View 9
Nuremberg 9
Dover 8
Düsseldorf 8
Nanjing 8
Norwalk 8
Auburn Hills 7
Bologna 7
Chennai 7
Guangzhou 7
Mexico City 7
San Francisco 7
Tokyo 7
Brooklyn 6
Florence 6
London 6
Louisville 6
Redwood City 6
Toronto 6
Amsterdam 5
Brno 5
Brusciano 5
Caerano di San Marco 5
Fortaleza 5
Frankfurt am Main 5
Houston 5
Stockholm 5
Turku 5
Vienna 5
Baghdad 4
Boston 4
Capaccio 4
Denver 4
Fermo 4
Istanbul 4
Jinan 4
Miami 4
Molfetta 4
Montreal 4
Mumbai 4
Nairobi 4
Newark 4
Ormskirk 4
Paris 4
Quarrata 4
Ribeirão das Neves 4
San Giorgio Del Sannio 4
Sant'Antonio Abate 4
Shijiazhuang 4
Tashkent 4
Vũng Tàu 4
Totale 6.707
Salva come PNG Salva come JPEG
Nome #
Tissue transglutaminase expression affects hypusine metabolism in BALB/c 3T3 cells 783
Un modello di malattia da poliglutammine: clinica e diagnosi della Corea di Huntington 250
Possible Roles of the Transglutaminases in the Molecular Mechanisms Responsible for Human Neurodegenerative Diseases 224
2-pentadecyl-2-oxazoline prevents cognitive and social behaviour impairments in the Amyloid β-induced Alzheimer-like mice model: Bring the α2 adrenergic receptor back into play 210
Abnormal accumulation of tTGase products in muscle and erythrocytes of chorea-acanthocytosis patients 201
A novel G-protein active on signal transduction 183
Meet Our Editorial Board Member 170
Amyloid-β-Induced Transglutaminase 2 Expression and Activities Are Modulated by 2-Pentadecyl-2-Oxazoline in Mouse and Human Microglial Cell Lines 169
Possible Roles of the Transglutaminases in the Molecular Mechanisms Responsible for Human Neurological Diseases 165
PHYSIOPATHOLOGICAL ROLES OF THE HUMAN TRANSGLUTAMINASE 2, THE “TISSUE” TRANSGLUTAMINASE (TG2), AND ITS POSSIBLE INVOLVEMENT IN NEURODEGENERATIVE DISEASES 160
Biochemical and morphological evidences supporting the hypothesis of a role of TGase in the pathogenesis of chorea acanthocytosis (C-A) 160
B-lipotropin 61-76 and 61-91 fragments act as transglutaminase substrates in vitro 157
Immune cell infiltration and inflammatory landscape in primary brain tumours 156
A Biochemical Mechanism for a Transglutaminase-Mediated Cell Death in CAG Triplet Diseases: Tissue Tranglutaminase-Catalyzed Formation of High Molecular Weight Aggregates With Extended Polyglutamine Peptides and Glyceraldehyde 3-Phospate Dehydrogenase 156
Cell-biomaterial interactions: role of transglutaminase enzyme 148
Neuronutraceuticals Modulate Lipopolysaccharide- or Amyloid-β 1-42 Peptide-Induced Transglutaminase 2 Overexpression as a Marker of Neuroinflammation in Mouse Microglial Cells 143
ESPRESSIONE DELLA TRANSGLUTAMINASI ENDOTELIALE IN TESSUTO DI PROSTATA NORMALE E CARCINOMATOSA E DELL’ATTIVITA’ TRANSGLUTAMINASICA IN CELLULE EPITELIALI DI PROSTATA NORMALE 142
Implication of transglutaminase in mitogen-induced human lymphocyte blast transformation 141
Biochemical and morphological evidences supporting the hypothesis of a role of TGase in the pathogenesis of chorea acanthocytosis (C-A) 140
Changes in tissue transglutaminase activity and expression during retinoic acid-induced growth arrest and apoptosis in primary cultures of human epithelial prostate cells 136
A role for an "heavy" G-protein on the modulation of the adenylate cyclase activity 134
Curcumin (Diferulolylmethane) Reduces Transglutaminase 2 Overexpression Induced by Retinoic Acid in Human Nervous Cell Lines 134
Biochemical mechanisms for a possible involvement of the transglutaminase activity in the pathogenesis of the polyglutamine diseases 133
Possible roles of transglutaminases in molecular mechanisms responsible for cancer and human neurodegenerative diseases. 132
Amines protect in vitro the celiac small intestine from the damaging activity of gliadin peptides 131
Use of Transglutaminase 2 mRNA expression in peripheral blood mononuclear cells in patients with Radiologically Isolated Syndrome as a neuroinflammation biomarker: A preliminary study. 126
Possible involvement of transglutaminase-catalyzed reactions in the physiopathology of neurodegenerative diseases 126
Possible physiopathological effects of the transglutaminase activity on the molecular mechanisms responsible for human neurodegenerative diseases 124
Are the methionine sulfoximine-induced seizures specifically related to the increase of spermine production? 122
Defective stabilization of apoptotic cells by “tissue transglutaminase” cross-linking of proteins in MRL lpr/lpr autoimmune mice 121
Cerebral polyamine metabolism: inhibition of spermidine biosynthesis by dicyclohexylamine 121
REGULATION OF TISSUE TRANSGLUTAMINASE AND APOPTOSIS IN HUMAN PROSTATE EPITHELIAL CELLS BY RETINOIC ACID. 121
Possible role of the Transglutaminases in the pathogenesis of Alzheimer's disease and other Neurodegenerative diseases 119
Cereal dietary proteins with sites for cross-linking by transglutaminase 118
Transglutaminase activity as a possible therapeutical target in neurodegenerative diseases 118
Tissue transglutaminase-catalyzed formation of high-molecular-weight aggregates in vitro is favored with long polyglutamine domains: a possible mechanism contributing to CAG-triplet diseases 115
Transglutaminase-Catalyzed Reactions Responsible for the Pathogenesis of Celiac Disease and Neurodegenerative Diseases: From Basic Biochemistry to Clinic 115
Transglutaminase inhibition: possible therapeutic mechanisms to protect cells from death in neurological disorders 115
Possible roles of transglutaminase-catalyzed reactions in the pathogenesis of human neurodegenerative diseases 114
Identification of a FXIIIA variant in human neuroblastoma cell lines. 114
What is the purpose of launching the Translational Medicine Reports journal? 113
Functional implications of human tissue transglutaminase in the modulation of signal transduction via G-proteins 111
Possible roles of the transglutaminase-catalyzed reactions in the pathogenesis of human neurodegenerative diseases 111
Transglutaminase inhibition: A therapy to protect cells from death in neurodegeneration? 110
Pathogenesis of inclusion bodies in (CAG)n/Qn-expansion diseases with special reference to the role of tissue transglutaminase and to selective vulnerability 108
Cross linking of polyglutamine domains catalyzed by tissue transglutaminase is greatly favored with pathological-length repeats: does transglutaminase activity play a role in (CAG)(n)/Q(n)-expansion diseases? 108
Identification and characterisation of brain transglutaminases and their possible involvement in the pathogenesis of polyglutamine diseases 108
Studio sull’espressione genica delle transglutaminasi e sul loro possibile ruolo nella patogenesi di malattie da poliglutammine 107
Transglutaminase inhibition as a possible therapeutical approach to protect cells from death in neurodegenerative diseases 106
Pathophysiological Roles of Transglutaminase - Catalyzed Reactions in the Pathogenesis of Human Diseases 106
Transglutaminase-mediated modifications of the rat sperm surface in vitro 105
Isolation and characterization of the human tissue transglutaminase gene promoter 104
tTGase/G alpha h protein expression inhibits adenylate cyclase activity in Balb-C 3T3 fibroblasts membranes 104
Possible roles of transglutaminases in molecular mechanisms responsible for human neurodegenerative diseases. 104
Purification and partial characterization of transglutaminase secreted from the rat anterior prostate 103
Possible role of the transglutaminase activity in molecular mechanisms responsible for human neurodegenerative diseases 102
Role of the Transglutaminase Enzymes in the Nervous System and their possible involvement in Neurodegenerative Diseases 101
Transglutaminase-dependent formation of protein aggregates as possible biochemical mechanism for polyglutamine diseases 101
Tissue transglutaminase (tTGase) a key enzyme in the pathogenesis of Huntington Corea and Neuroacanthocytosis 101
Expression of tissue transglutaminase in Balb-C 3T3 fibroblasts: effects on cellular morphology and adhesion 100
Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases 99
Possible physiopathological roles of the transglutaminase activity in the etiopathogenesis of human neurodegenerative diseases 99
Transglutaminases: a possible role in (CAG)n/Qn-expansion diseases and selective vulnerability? 98
Human tissue transglutaminase gene clone as device for detecting celiac disease 98
Transglutaminases - possible drug targets in human diseases 97
Retinoid-regulated expression of transglutaminases: links to the biochemistry of cell death 97
Transglutaminases as Possible Therapeutic Targets in Neurodegenerative Diseases 95
Role of transglutaminase in the maturation of mammalian spermatozoon 94
Striking homology between transglutaminase secreted by the rat coagulating gland and the cDNA-derived amino acid sequence of DP1, a protein occurring in both anterior and dorsal rat prostate 94
Physiopathological roles of human transglutaminase 2 94
Transglutaminase activity in rat jejunal mucosa: possible role of the enzyme in the pathogenesis of gluten sensitive enteropathy 93
Transglutaminase inhibition: possible therapeutic mechanisms to protect cells from death in neurological disorders. 93
The human tissue transglutaminase gene maps on chromosome 20q12 by in situ fluorescence hybridization 92
Possible pathophysiological roles of transglutaminase - catalyzed reactions in the pathogenesis of human neurodegenerative diseases 91
Transglutaminase Activity as a Possible Molecular Mechanism in the Etiopathogenesis of Neurodegenerative Diseases 91
Suppression of rat epididymal sperm antigenicity in vitro by transglutaminase and one of the major protein secreted from the rat seminal vesicle epithelium (SV-IV) 90
Hyperckemia in the neuroacanthocytosis: possible tissutal transglutaminase abnormality in skeletal muscle 90
L' esperienza del neurologo: la Corea di Huntington 89
Factors modulating immunocompatibility of spermatozoa: role of transglutaminase and SV-IV, one of the major protein secreted from the rat seminal vesicle epithelium 89
Transglutaminase-catalyzed post-translational modifications of proteins in the Nervous System and their possible involvement in Neurodegenerative Diseases 88
Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells 88
Tissue transglutaminase expression in Balb-c 3T3 fibroblasts affects hypusine metabolism 87
Occurrence of spermine binding sites in synaptosomal membranes 87
Immunologic properties of rat coagulating gland transglutaminase 86
Transglutaminase-catalyzed modifications of SV-IV, a major protein secreted from the rat seminal vesicle epithelium 86
Possible Role of the Transglutaminases in the Pathogenesis of Neurodegenerative Diseases 86
Tissue transglutaminase expression in quail epiphyseal chondrocytes 84
Possible role of the transglutaminase-catalyzed reactions in the pathogenesis of neurodegenerative diseases 84
Physio-pathological roles of the transglutaminase-catalyzed reactions 82
Role of Transglutaminase-Catalyzed Reactions in the Post-Translational Modifications of Proteins Responsible for Immunological Disorders 81
Molecular mechanisms responsible for the involvement of tissue transglutaminase in human diseases: celiac disease 81
Transglutaminase Inhibition as a Possible Therapeutic Mechanism to Protect Cells from Death in Neurological Disorders 79
Tissue transglutaminase and coeliac disease pathogenesis: potential molecular mechanisms for other human diseases 78
The importance of the GTP-binding protein tissue transglutaminase in the regulation of cell cycle progression 78
Studies on human semen transglutaminase 78
Spermine binding to subsynaptosomal fractions of rat brain cortex 77
Localization of the human prostate transglutaminase (type IV) gene (TGM4) to chromosome 3p21.33-p22 by fluorescence in situ hybridization 77
Polyamines and methionine sulfoximine-induced seizures 77
Transglutaminase covalently incorporates amines into human immunodeficiency virus envelope glycoprotein gp120 in vitro 76
Transfection of tissue transglutaminase into a highly malignant hamster fibrosarcoma leads to a reduced incidence of primary tumour growth 76
Totale 12.059
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.494
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.494
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202134 0 0 0 0 0 0 0 0 0 0 0 34
2021/2022575 58 16 2 11 198 6 26 9 28 10 52 159
2022/20231.274 125 20 26 138 95 102 1 79 623 8 24 33
2023/2024533 36 18 29 51 181 25 3 19 8 9 41 113
2024/20251.393 8 18 22 36 220 202 136 116 140 336 102 57
2025/20266.156 177 265 269 296 439 3.149 325 109 853 76 157 41
Totale 12.059